Quantum Biopharma-B Sub VotQNTM
13F holders, Q1 2025 (March 31)14holders +5
7new positions
2sold out
$7.90avg. 13F price*
At the end of Q1 2025, 14 institutions reported holding Quantum Biopharma-B Sub Vot (QNTM) in their 13F filings, up 5 from Q4 2024. 7 opened new positions and 2 sold out. The largest holders were AdvisorShares Investments LLC ($391K), J.W. Cole Advisors, Inc. ($97K) and Tower Research Capital LLC (TRC) ($25K).
- Company
- Quantum Biopharma-B Sub Vot
- CUSIP
- 74764Y205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $158K |
| Exits | 2 | $66 |
All 13F filers, Q4 2024 → Q1 2025: 20,636 shares bought and 20,484 shares sold, net +152 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| AdvisorShares Investments LLC | 0.08% | Reduce -29.1% | 48,990 | $391K |
| J.W. Cole Advisors, Inc. | 0.00% | New | 12,590 | $97K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 3,195 | $25K |
| Morgan Stanley | 0.00% | New | 2,532 | $20K |
| UBS Group AG | 0.00% | New | 1,614 | $12K |
| Thompson Investment Management, Inc. | 0.00% | New | 325 | $3K |
| Cetera Trust Company, N.A | 0.00% | New | 250 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +57.0% | 157 | $1K |
| Group One Trading LLC | 0.00% | Reduce -13.5% | 115 | $887 |
| National Bank of Canada | 0.00% | Add +170.6% | 92 | $729 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 28 | $209 |
| Activest Wealth Management | 0.00% | New | 15 | $116 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 2 | $16 |
| Royal Bank of Canada | 0.00% | Reduce -95.0% | 19 | $0 |
"% of holder's portfolio" is QNTM's weight in each manager's 13F, not the share of Quantum Biopharma-B Sub Vot the manager owns.